Screening | Double blind | Open label | ||||||
---|---|---|---|---|---|---|---|---|
Inclusion/exclusion criteria | X | |||||||
Informed consent | X | |||||||
Active treatment | X | X | X | X | X | X | X | |
Placebo | X | X | X | X | ||||
Skin Prick Tests | X | X | X | X | X | X | X | X |
Glove Use Test | X | X | X | |||||
Conjunctival Challenge | X | X | X | |||||
IgE | X | X | X | |||||
Basophil Activation Test | X | X | X | |||||
Adverse events | X | X | X | X | X | X | X | |
Months | 0 | 1 | 6 | 12 | 13 | 18 | 24 |